ABOUT US

E3A Healthcare was established in 2019 on the campus of the National University of Singapore. The name “E3A” comes from the name of the Bioengineering Building at NUS, where the company was born.

We seek to become a globally leading provider of innovative newborn and women’s healthcare devices and management solutions, committed to delivering first-in-class medical devices and integrated medical IoT solutions for newborn and women’s healthcare, providing diagnosis, treatment, and management solutions from pregnancy to parenting.

E3A Healthcare

Company Timeline

2019

Our journey began with a vision to improve the quality of care for newborns and women worldwide. Established at NUS in 2019, we embarked on our journey to create accessible and effective medical devices that addresses overlooked demands

2020

In 2020, we initiated the development of our first product - the YSJ series smart newborn jaundice meters. We also established our Hong Kong and Shenzhen offices to expand into the Greater China markets

2021

In 2021, we finished the development and clinical trials for our YSJ series bilirubin meter product. Furthermore, We have completed the setup of a medical device manufacturing facility in Shenzhen, which is certified with ISO-13485 standards., finalizing our capabilities for in-house development and fabrication of innovative medical devices

2022

We received Class II medical device clearance for our smart jaundice meter product from the Chinese FDA (NMPA) and pioneered the rental model for at-home jaundice monitoring. Currently, we serve over 120 hospitals across China, covering over 500K newborns annually

2023

We have showcased its outstanding technology and innovation on the international stage, from the Asian Technology Event to the Global Biotechnology event and Slush 2023 Showcase. The company was revitalized through a financing partnership with Capital Asia Investments, participation in the Foreign Enterprises Roundtable of the Ministry of Commerce of China, and a new strategic partnership with Shenzhen Qianhai Services Group. The fourth anniversary celebration and award-winning events showcased E3A Healthcare's achievements in medical technology. We remain committed to innovation and providing advanced solutions to the needs of newborn and women, while maintaining a humble approach.

2024 and Beyond

In 2024, we will enter a new era of medical technology with ambitious goals. We will continue to challenge ourselves to pursue more advanced technology and more caring services. We will deepen our global collaborations and expand into Southeast Asia and North America. Additionally, we plan to launch our first women's health device in 2024.

Dr.Rishav

Ex-Physician; Former Research Director at Nepal Science Institute; Received Masters in Public Health from Johns Hopkins and BioEngPh.D. from NUS

Dr. Rishav Shrestha
Chief Technology Officer
Dr.Dieter

Dean, AIT College of Engineering, Professor at NUS; Esteemed scholar in analytical chemistry;Founder of multiple biotech companies, raised over 60M USD

Dr.Dieter Trau
Chief Scientific Officer
Harry Chen

Serial Biotech Entrepreneur, previous company acquired; California CPA; Former Silicon Valley Investor; Studied Economics at UC Berkeley

Harry Chen, CPA
Chief Financial Officer
Dr.Shawn

2021 Forbes 30 Under 30 ; Optoelectronics expert; Former PI in multiple SG National Science Foundation projects; Received Ph.D. in Bioengineering from NUS

Dr.Shawn Li
CEO and Founder

Management Team

Roy

Fellow of the Royal College of Paediatrics and Child Health in the UK, expert in neonatal clinical medicine; former head of neonatology at the NUH in Singapore; leader in maternal and child health care in Singapore

Roy Joseph FRCPCH
Chief Clinical Advisor
Randel Frazier

Former Chief Technology Officer of Medtronic, Vice President of Covidien; experienced expert in the medical device industry, managing over $10 billion in annual revenue

Randel Frazier
Chief Technical Advisor
John Speakman FRS

Top scholars in the fields of metabolism, animal physiology, and genomics; current member of the editorial board of Science journal; academicians of the national academies of sciences in China, US and UK.

John Speakman FRS
Chief Science Advisor

Advisory Team

Singapore
HongKong
Shenzhen
Silicon Valley

OUR OFFICES


Singapore

*Headquarters

83 Science Park Road, #02-03, Curie, 118258

Unit 502, Building 19W, HKSTP, Pak Shek Kok, N.T., HKSAR

Hong Kong

16F, Tower B, ITH, Nanshan, Shenzhen, Guangdong, China

Shenzhen

Silicon Valley

1520 Sand Hill Road, Palo Alto, CA, United States, 94304